Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Poitiers University Hospital
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients Broncho Chronic Obstructive Pulmonary Disease in stages 2 and 3 of the GOLD classification, whose Maximum Expiratory Volume on the first second is between 30% and 80% of the expected theoretical value, associated with a maximal expiratory volume ratio on the first Second / Vital Capacity less than or equal to 70% of the expected theoretical value.
Patients of both sexes, aged 40 to 80 years
In case of active smoking, patients must commit to interrupting it during the respiratory rehabilitation program that will be proposed to them in this study
You may not be if
\- Age \<40 years or\> 80 years
Patients with a contraindication to exercise,
Phenylketonuria
Patients treated with long-term oxygen therapy and / or home ventilation will not be included.
Patients with acute respiratory decompensation in the three months prior to inclusion.
Patients with known allergy to milk, gluten, soy, egg and nuts
Patients taking part in another clinical trial or who have participated in a clinical trial in the 3 months preceding this study.
Clareo Health | Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease
